SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on December 1, 2021. The registrant is incorporated in Delaware and trades on the NASDAQ Capital Market under the symbol BSGM. The report primarily addresses a corporate governance update rather than financial performance.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a current report regarding a specific event and does not contain financial statements or performance data.
Material Changes
The material change disclosed in this filing is the appointment of Gray Fleming as the Company's Chief Commercial Officer, announced via a press release on December 1, 2021.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding future performance. The Company explicitly states it undertakes no obligation to update, supplement, or amend the materials attached. No specific risks or contingencies are detailed in this report.
Investor Verification Checklist
- Verify the official press release (Exhibit 99.1) for details on Gray Fleming's background and start date.
- Confirm the Company's current financial status by reviewing the most recent 10-K or 10-Q filings, as this 8-K contains no financial data.
- Monitor future filings for any updates regarding the new Chief Commercial Officer's strategic initiatives.